Literature DB >> 12911316

Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation.

Jennifer S Pickett1, Katherine E Bowers, Heather L Hartman, Hua-Wen Fu, Alan C Embry, Patrick J Casey, Carol A Fierke.   

Abstract

The zinc metalloenzyme protein farnesyltransferase (FTase) catalyzes the transfer of a 15-carbon farnesyl moiety from farnesyl diphosphate (FPP) to a cysteine residue near the C-terminus of a protein substrate. Several crystal structures of inactive FTase.FPP.peptide complexes indicate that K164alpha interacts with the alpha-phosphate and that H248beta and Y300beta form hydrogen bonds with the beta-phosphate of FPP [Strickland, C. L., et al. (1998) Biochemistry 37, 16601-16611]. Mutations K164Aalpha, H248Abeta, and Y300Fbeta were prepared and analyzed by single turnover kinetics and ligand binding studies. These mutations do not significantly affect the enzyme affinity for FPP but do decrease the farnesylation rate constant by 30-, 10-, and 500-fold, respectively. These mutations have little effect on the pH and magnesium dependence of the farnesylation rate constant, demonstrating that the side chains of K164alpha, Y300beta, and H248beta do not function either as general acid-base catalysts or as magnesium ligands. Mutation of H248beta and Y300beta, but not K164alpha, decreases the farnesylation rate constant using farnesyl monophosphate (FMP). These data suggest that, contrary to the conclusions derived from analysis of the static crystal structures, the transition state for farnesylation is stabilized by interactions between the alpha-phosphate of the isoprenoid substrate and the side chains of Y300beta and H248beta. These results suggest an active substrate conformation for FTase wherein the C1 carbon of the FPP substrate moves toward the zinc-bound thiolate of the protein substrate to react, resulting in a rearrangement of the diphosphate group relative to its ground state position in the binding pocket.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911316     DOI: 10.1021/bi0346852

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Finding a needle in the haystack: computational modeling of Mg2+ binding in the active site of protein farnesyltransferase.

Authors:  Yue Yang; Dhruva K Chakravorty; Kenneth M Merz
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

Review 2.  Unraveling the mechanism of the farnesyltransferase enzyme.

Authors:  Sérgio Filipe Sousa; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  J Biol Inorg Chem       Date:  2004-12-21       Impact factor: 3.358

3.  Molecular dynamics analysis of a series of 22 potential farnesyltransferase substrates containing a CaaX-motif.

Authors:  Sérgio F Sousa; João T S Coimbra; Diogo Paramos; Rita Pinto; Rodrigo S Guimarães; Vitor Teixeira; Pedro A Fernandes; Maria J Ramos
Journal:  J Mol Model       Date:  2012-09-26       Impact factor: 1.810

4.  Structures of Cryptococcus neoformans protein farnesyltransferase reveal strategies for developing inhibitors that target fungal pathogens.

Authors:  Michael A Hast; Connie B Nichols; Stephanie M Armstrong; Shannon M Kelly; Homme W Hellinga; J Andrew Alspaugh; Lorena S Beese
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

5.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

6.  Computational studies of the farnesyltransferase ternary complex part I: substrate binding.

Authors:  Guanglei Cui; Bing Wang; Kenneth M Merz
Journal:  Biochemistry       Date:  2005-12-20       Impact factor: 3.162

7.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

8.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

9.  Computational studies of the farnesyltransferase ternary complex part II: the conformational activation of farnesyldiphosphate.

Authors:  Guanglei Cui; Kenneth M Merz
Journal:  Biochemistry       Date:  2007-10-06       Impact factor: 3.162

10.  Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.

Authors:  Thangaiah Subramanian; June E Pais; Suxia Liu; Jerry M Troutman; Yuta Suzuki; Karunai Leela Subramanian; Carol A Fierke; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.